- Genetic Testing Proves Significant in Identifying Somatic and Germline Mutations in Prostate Cancer.
- Hollasch M, Antonarakis ES.
- OncLive. 2022 Nov 11.
- Review
- Free Full Text
Category: Provider Education
- From the patient to the population: Use of genomics for population screening.
- Mighton C, Shickh S, Aguda V, Krishnapillai S, Adi-Wauran E, Bombard Y.
- Front Genet. 2022 Oct 24;13:893832. doi: 10.3389/fgene.2022.893832.
- PMID: 36353115
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
LitAlert ~~ GeneLit.com
- Latinx attitudes, barriers, and experiences with genetic counseling and testing: A systematic review.
- Dron HA, Bucio D, Young JL, Tabor HK, Cho MK.
- J Genet Couns. 2022 Oct 27. doi: 10.1002/jgc4.1632. Epub ahead of print.
- PMID: 36301246
- PubMed abstract
- Review
- Free Full Text
- Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline.
- Sessa C, Balmaña J, Bober SL, Cardoso MJ, Colombo N, Curigliano G, Domchek SM, Evans DG, Fischerova D, Harbeck N, Kuhl C, Lemley B, Levy-Lahad E, Lambertini M, Ledermann JA, Loibl S, Phillips KA, Shimon P; ESMO Guidelines Committee.
- Ann Oncol. 2022 Oct 19:S0923-7534(22)04193-X. doi: 10.1016/j.annonc.2022.10.004. Epub ahead of print.
- PMID: 36307055
- PubMed abstract
- Guideline
- Free Full Text
- Hereditary Breast and Ovarian Cancer Service in Sparsely Populated Western Pomerania.
- Felbor U, Bülow R, Schmutzler RK, Rath M.
- Healthcare (Basel). 2022 Oct 13;10(10):2021. doi: 10.3390/healthcare10102021.
- PMID: 36292468
- PubMed abstract
- Source abstract
- Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers.
- Clark NM, Roberts EA, Fedorenko C, Sun Q, Dubard-Gault M, Handford C, Yung R, Cheng HH, Sham JG, Norquist BM, Flanagan MR.
- Ann Surg Oncol. 2022 Nov 5. doi: 10.1245/s10434-022-12755-y. Epub ahead of print.
- PMID: 36335273
- PubMed abstract
- Source abstract
LitAlert ~~ GeneLit.com
- Reducing the risk of breast cancer.
- Pederson HJ, Al-Hilli Z, Kurian AW.
- Cleve Clin J Med. 2022 Nov 1;89(11):643-652. doi: 10.3949/ccjm.89a.21113.
- PMID: 36319046
- PubMed abstract
- Review
- Free Full Text
- Myriad Genetics to Submit Hereditary Cancer Risk Variants to ClinVar in 2023.
- Ray T.
- GenomeWeb. 2022 Nov 1.
- News
- Relatives from Hereditary Breast and Ovarian Cancer and Lynch Syndrome Families Forgoing Genetic Testing: Findings from the Swiss CASCADE Cohort.
- Sarki M, Ming C, Aceti M, Fink G, Aissaoui S, Bürki N, Graffeo R, Heinimann K, Zufferey MC, Monnerat C, Rabaglio M, Zürrer-Härdi U, Chappuis PO, Katapodi MC.
- J Pers Med. 2022 Oct 19;12(10):1740. doi: 10.3390/jpm12101740.
- How should we address the inevitable harms from non-negligent variant reclassification in predictive genetic testing?
- Rashkin M, Kingham K, Lara-Otero , Mckenna M, Villiers J, Worthington MM, Prince A.
- J Genet Couns. 2022 Oct 19. doi: 10.1002/jgc4.1638. Epub ahead of print.
- Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study.
- Shirota H, Komine K, Takahashi M, Takahashi S, Miyauchi E, Niizuma H, Tada H, Shimada M, Niihori T, Aoki Y, Sugiyama I, Kawamura M, Yasuda J, Suzuki S, Iwaya T, Saito M, Saito T, Shibata H, Furukawa T, Ishioka C.
- Cancer Med. 2022 Oct 17. doi: 10.1002/cam4.5349. Epub ahead of print.
- PMID: 36251535
- PubMed abstract
- Source abstract
- Genetic Testing Challenges in Oncology: Missed Variant Update Delays Li-Fraumeni Diagnosis.
- Ray T.
- Precision Oncology News. 2022 Oct 12.
- Case report
- Free Full Text
Special article:
Is there a duty to reinterpret genetic data? The ethical dimensions.
- PMID: 31616070
- PubMed abstract
- Free Full Text
- Study: Teens and young adults respond well to learning about familial cancer risk
- [No author given]
- FORCE. XRAY. 2022 Oct 11.
- Research news
- Free Full Text
Original research:
Long-Term Adaptation Among Adolescent and Young Adult Children to Familial Cancer Risk.
- PMID: 35859209
- PubMed abstract
- Source abstract
Commentary:
Breaking Down the Barriers of Hereditary Cancer Risk Disclosure in AYA.
- PMID: 35859132
- PubMed abstract
- Source abstract